Monitoring Blood Pressure at Home

Hypertension Clinical Trial

Official title:

Post-Emergency Department Discharge Clinic Telehealth Program for Patients With Uncontrolled Hypertension: a Pilot Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06247111
• Other study ID #: IRB-300012428
• Secondary ID: P50MD017338
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 2024
• Est. completion date: June 2027

Study information

• Verified date: January 2024
• Source: University of Alabama at Birmingham
• Contact: Lama Ghazi, MD, PhD
• Phone: 205-552-3045
• Email: lghazi[@]uab.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage your blood pressure is feasible. The study will enroll 24 participants at UAB. Half of the participants (12 patients) will be asked to measure their blood pressure at home, and half of the participants (12 patients) will continue to receive usual care. Participants who measure their blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 3 months.

Description:

For all participants:

1. Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure.

2. Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs.

3. Participants will come in for one research clinic visit to get blood pressure measured 3 months after enrollment in this study.

For participants asked to measure blood pressure at home:

1. Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders each week day. Participants will return the device at study visit 3 months from now.

2. Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician.

3. Participants will complete questionnaires on satisfaction with the program.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 24
• Est. completion date: June 2027
• Est. primary completion date: June 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients seen at the Emergency Department Post-Discharge Clinic

• >=18 years

• Blood pressure >=130/80 mmHg and <=160/100 mmHg

• English speakers

• Have a smartphone

Exclusion Criteria:

• Patients with blood pressure >=160 mmHg

Related Conditions & MeSH terms

• Hypertension

Intervention

Other:
• Remote Blood Pressure Monitoring + Telehealth
Remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
• Usual care
Participants receive usual care, no intervention.

Locations

Country	Name	City	State
United States	University of Alabama at Birmingham	Birmingham	Alabama

Sponsors (2)

Lead Sponsor	Collaborator
University of Alabama at Birmingham	National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Total number of recruited participants	Measuring number of eligible participants that enroll in the study	2 years